Inhibitory Effects of Eriodictyol-7-O-β-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from Chrysanthemum zawadskii var. latilobum in FcεRI-Mediated Human Basophilic KU812F Cell Activation.
Identifieur interne : 000130 ( Main/Exploration ); précédent : 000129; suivant : 000131Inhibitory Effects of Eriodictyol-7-O-β-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from Chrysanthemum zawadskii var. latilobum in FcεRI-Mediated Human Basophilic KU812F Cell Activation.
Auteurs : Mina Lee [Corée du Sud] ; Sun-Yup Shim [Corée du Sud]Source :
- Molecules (Basel, Switzerland) [ 1420-3049 ] ; 2020.
Descripteurs français
- KwdFr :
- Antiallergiques (isolement et purification), Antiallergiques (pharmacologie), Benzopyranes (composition chimique), Benzopyranes (pharmacologie), Calcium (métabolisme), Chrysanthemum (composition chimique), Dégranulation cellulaire (effets des médicaments et des substances chimiques), Extraits de plantes (isolement et purification), Extraits de plantes (pharmacologie), Flavanones (isolement et purification), Flavanones (pharmacologie), Glucuronates (isolement et purification), Glucuronates (pharmacologie), Granulocytes basophiles (effets des médicaments et des substances chimiques), Humains (MeSH), Lignée cellulaire (MeSH), Protein-tyrosine kinases (métabolisme), Récepteurs aux IgE (métabolisme), Structure moléculaire (MeSH), Système de signalisation des MAP kinases (MeSH).
- MESH :
- composition chimique : Benzopyranes, Chrysanthemum.
- effets des médicaments et des substances chimiques : Dégranulation cellulaire, Granulocytes basophiles.
- isolement et purification : Antiallergiques, Extraits de plantes, Flavanones, Glucuronates.
- métabolisme : Calcium, Protein-tyrosine kinases, Récepteurs aux IgE.
- pharmacologie : Antiallergiques, Benzopyranes, Extraits de plantes, Flavanones, Glucuronates.
- Humains, Lignée cellulaire, Structure moléculaire, Système de signalisation des MAP kinases.
English descriptors
- KwdEn :
- Anti-Allergic Agents (isolation & purification), Anti-Allergic Agents (pharmacology), Basophils (drug effects), Benzopyrans (chemistry), Benzopyrans (pharmacology), Calcium (metabolism), Cell Degranulation (drug effects), Cell Line (MeSH), Chrysanthemum (chemistry), Flavanones (isolation & purification), Flavanones (pharmacology), Glucuronates (isolation & purification), Glucuronates (pharmacology), Humans (MeSH), MAP Kinase Signaling System (MeSH), Molecular Structure (MeSH), Plant Extracts (isolation & purification), Plant Extracts (pharmacology), Protein-Tyrosine Kinases (metabolism), Receptors, IgE (metabolism).
- MESH :
- chemical , chemistry : Benzopyrans.
- chemical , isolation & purification : Anti-Allergic Agents, Flavanones, Glucuronates, Plant Extracts.
- chemical , metabolism : Calcium, Protein-Tyrosine Kinases, Receptors, IgE.
- chemical , pharmacology : Anti-Allergic Agents, Benzopyrans, Flavanones, Glucuronates, Plant Extracts.
- chemistry : Chrysanthemum.
- drug effects : Basophils, Cell Degranulation.
- Cell Line, Humans, MAP Kinase Signaling System, Molecular Structure.
Abstract
Chrysanthemum zawadskii var. latilobum (CZL) has been used in Eastern medicine for the treatment of various diseases, such as pneumonia, bronchitis, cough, the common cold, pharyngitis, bladder-related disorders, gastroenteric disorders, and hypertension. In the present study, we isolated two strong antiallergic compounds from CZL, namely, eriodictyol-7-O-β-d-glucuronide (EDG) and 5,7-dihydroxy-4-chromene (DC), and investigated their antiallergic effects in FcεRI-mediated human basophilic KU812F cells. EDG and DC downregulated the protein and messenger RNA (mRNA) expression of FcεRI on the cell surface. Moreover, Western blotting analysis showed that EDG and DC inhibited the expression of protein tyrosine kinases such as Syk and Lyn, and extracellular-regulated kinases (ERK) 1/2. These results suggested that EDG and DC, antiallergic constituents of CZL, are potential therapeutic candidates for protection against and for the treatment of allergic disorders.
DOI: 10.3390/molecules25040994
PubMed: 32102220
PubMed Central: PMC7070965
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhibitory Effects of Eriodictyol-7-<i>O</i>-<i>β</i>-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from <i>Chrysanthemum zawadskii</i> var. <i>latilobum</i> in FcεRI-Mediated Human Basophilic KU812F Cell Activation.</title><author><name sortKey="Lee, Mina" sort="Lee, Mina" uniqKey="Lee M" first="Mina" last="Lee">Mina Lee</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si, Jeonnam 57922, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si, Jeonnam 57922</wicri:regionArea><wicri:noRegion>Jeonnam 57922</wicri:noRegion></affiliation></author><author><name sortKey="Shim, Sun Yup" sort="Shim, Sun Yup" uniqKey="Shim S" first="Sun-Yup" last="Shim">Sun-Yup Shim</name><affiliation wicri:level="1"><nlm:affiliation>Department of Aqualife Science, College of Fisheries and Ocean Sciences, Chonnam National University, 50 Daehak-Ro, Yeosu, Jeonnam 59626, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Aqualife Science, College of Fisheries and Ocean Sciences, Chonnam National University, 50 Daehak-Ro, Yeosu, Jeonnam 59626</wicri:regionArea><wicri:noRegion>Jeonnam 59626</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32102220</idno><idno type="pmid">32102220</idno><idno type="doi">10.3390/molecules25040994</idno><idno type="pmc">PMC7070965</idno><idno type="wicri:Area/Main/Corpus">000202</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000202</idno><idno type="wicri:Area/Main/Curation">000202</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000202</idno><idno type="wicri:Area/Main/Exploration">000202</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inhibitory Effects of Eriodictyol-7-<i>O</i>-<i>β</i>-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from <i>Chrysanthemum zawadskii</i> var. <i>latilobum</i> in FcεRI-Mediated Human Basophilic KU812F Cell Activation.</title><author><name sortKey="Lee, Mina" sort="Lee, Mina" uniqKey="Lee M" first="Mina" last="Lee">Mina Lee</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si, Jeonnam 57922, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si, Jeonnam 57922</wicri:regionArea><wicri:noRegion>Jeonnam 57922</wicri:noRegion></affiliation></author><author><name sortKey="Shim, Sun Yup" sort="Shim, Sun Yup" uniqKey="Shim S" first="Sun-Yup" last="Shim">Sun-Yup Shim</name><affiliation wicri:level="1"><nlm:affiliation>Department of Aqualife Science, College of Fisheries and Ocean Sciences, Chonnam National University, 50 Daehak-Ro, Yeosu, Jeonnam 59626, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Aqualife Science, College of Fisheries and Ocean Sciences, Chonnam National University, 50 Daehak-Ro, Yeosu, Jeonnam 59626</wicri:regionArea><wicri:noRegion>Jeonnam 59626</wicri:noRegion></affiliation></author></analytic><series><title level="j">Molecules (Basel, Switzerland)</title><idno type="eISSN">1420-3049</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Allergic Agents (isolation & purification)</term><term>Anti-Allergic Agents (pharmacology)</term><term>Basophils (drug effects)</term><term>Benzopyrans (chemistry)</term><term>Benzopyrans (pharmacology)</term><term>Calcium (metabolism)</term><term>Cell Degranulation (drug effects)</term><term>Cell Line (MeSH)</term><term>Chrysanthemum (chemistry)</term><term>Flavanones (isolation & purification)</term><term>Flavanones (pharmacology)</term><term>Glucuronates (isolation & purification)</term><term>Glucuronates (pharmacology)</term><term>Humans (MeSH)</term><term>MAP Kinase Signaling System (MeSH)</term><term>Molecular Structure (MeSH)</term><term>Plant Extracts (isolation & purification)</term><term>Plant Extracts (pharmacology)</term><term>Protein-Tyrosine Kinases (metabolism)</term><term>Receptors, IgE (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antiallergiques (isolement et purification)</term><term>Antiallergiques (pharmacologie)</term><term>Benzopyranes (composition chimique)</term><term>Benzopyranes (pharmacologie)</term><term>Calcium (métabolisme)</term><term>Chrysanthemum (composition chimique)</term><term>Dégranulation cellulaire (effets des médicaments et des substances chimiques)</term><term>Extraits de plantes (isolement et purification)</term><term>Extraits de plantes (pharmacologie)</term><term>Flavanones (isolement et purification)</term><term>Flavanones (pharmacologie)</term><term>Glucuronates (isolement et purification)</term><term>Glucuronates (pharmacologie)</term><term>Granulocytes basophiles (effets des médicaments et des substances chimiques)</term><term>Humains (MeSH)</term><term>Lignée cellulaire (MeSH)</term><term>Protein-tyrosine kinases (métabolisme)</term><term>Récepteurs aux IgE (métabolisme)</term><term>Structure moléculaire (MeSH)</term><term>Système de signalisation des MAP kinases (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Benzopyrans</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Anti-Allergic Agents</term><term>Flavanones</term><term>Glucuronates</term><term>Plant Extracts</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Calcium</term><term>Protein-Tyrosine Kinases</term><term>Receptors, IgE</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Allergic Agents</term><term>Benzopyrans</term><term>Flavanones</term><term>Glucuronates</term><term>Plant Extracts</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Chrysanthemum</term></keywords><keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr"><term>Benzopyranes</term><term>Chrysanthemum</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Basophils</term><term>Cell Degranulation</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Dégranulation cellulaire</term><term>Granulocytes basophiles</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Antiallergiques</term><term>Extraits de plantes</term><term>Flavanones</term><term>Glucuronates</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Calcium</term><term>Protein-tyrosine kinases</term><term>Récepteurs aux IgE</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiallergiques</term><term>Benzopyranes</term><term>Extraits de plantes</term><term>Flavanones</term><term>Glucuronates</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cell Line</term><term>Humans</term><term>MAP Kinase Signaling System</term><term>Molecular Structure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Lignée cellulaire</term><term>Structure moléculaire</term><term>Système de signalisation des MAP kinases</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><i>Chrysanthemum zawadskii</i> var. <i>latilobum</i> (CZL) has been used in Eastern medicine for the treatment of various diseases, such as pneumonia, bronchitis, cough, the common cold, pharyngitis, bladder-related disorders, gastroenteric disorders, and hypertension. In the present study, we isolated two strong antiallergic compounds from CZL, namely, eriodictyol-7-<i>O</i>-<i>β</i>-d-glucuronide (EDG) and 5,7-dihydroxy-4-chromene (DC), and investigated their antiallergic effects in FcεRI-mediated human basophilic KU812F cells. EDG and DC downregulated the protein and messenger RNA (mRNA) expression of FcεRI on the cell surface. Moreover, Western blotting analysis showed that EDG and DC inhibited the expression of protein tyrosine kinases such as Syk and Lyn, and extracellular-regulated kinases (ERK) 1/2. These results suggested that EDG and DC, antiallergic constituents of CZL, are potential therapeutic candidates for protection against and for the treatment of allergic disorders.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32102220</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Inhibitory Effects of Eriodictyol-7-<i>O</i>-<i>β</i>-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from <i>Chrysanthemum zawadskii</i> var. <i>latilobum</i> in FcεRI-Mediated Human Basophilic KU812F Cell Activation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E994</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules25040994</ELocationID><Abstract><AbstractText><i>Chrysanthemum zawadskii</i> var. <i>latilobum</i> (CZL) has been used in Eastern medicine for the treatment of various diseases, such as pneumonia, bronchitis, cough, the common cold, pharyngitis, bladder-related disorders, gastroenteric disorders, and hypertension. In the present study, we isolated two strong antiallergic compounds from CZL, namely, eriodictyol-7-<i>O</i>-<i>β</i>-d-glucuronide (EDG) and 5,7-dihydroxy-4-chromene (DC), and investigated their antiallergic effects in FcεRI-mediated human basophilic KU812F cells. EDG and DC downregulated the protein and messenger RNA (mRNA) expression of FcεRI on the cell surface. Moreover, Western blotting analysis showed that EDG and DC inhibited the expression of protein tyrosine kinases such as Syk and Lyn, and extracellular-regulated kinases (ERK) 1/2. These results suggested that EDG and DC, antiallergic constituents of CZL, are potential therapeutic candidates for protection against and for the treatment of allergic disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si, Jeonnam 57922, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Sun-Yup</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Aqualife Science, College of Fisheries and Ocean Sciences, Chonnam National University, 50 Daehak-Ro, Yeosu, Jeonnam 59626, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018926">Anti-Allergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001578">Benzopyrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044950">Flavanones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005965">Glucuronates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017455">Receptors, IgE</NameOfSubstance></Chemical><Chemical><RegistryNumber>133360-47-1</RegistryNumber><NameOfSubstance UI="C068767">eriodictyol 7-glucuronide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018926" MajorTopicYN="N">Anti-Allergic Agents</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001491" MajorTopicYN="N">Basophils</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001578" MajorTopicYN="N">Benzopyrans</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015550" MajorTopicYN="N">Cell Degranulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D031202" MajorTopicYN="N">Chrysanthemum</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044950" MajorTopicYN="N">Flavanones</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005965" MajorTopicYN="N">Glucuronates</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017455" MajorTopicYN="N">Receptors, IgE</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5,7-dihydroxy-4-chromene</Keyword><Keyword MajorTopicYN="N">Chrysanthemum zawadskii var. latilobum</Keyword><Keyword MajorTopicYN="N">FcεRI</Keyword><Keyword MajorTopicYN="N">eriodictyol-7-O-β-d-glucuronide</Keyword><Keyword MajorTopicYN="N">extracellular regulated kinases 1/2</Keyword><Keyword MajorTopicYN="N">histamine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32102220</ArticleId><ArticleId IdType="pii">molecules25040994</ArticleId><ArticleId IdType="doi">10.3390/molecules25040994</ArticleId><ArticleId IdType="pmc">PMC7070965</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Front Immunol. 2020 Jan 28;11:50</Citation><ArticleIdList><ArticleId IdType="pubmed">32063904</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2010 Dec 15;584(24):4933-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20696166</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1989 Jan 12;337(6203):187-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2521376</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 1991 May;21(3):269-79</Citation><ArticleIdList><ArticleId IdType="pubmed">1830826</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Dec 6;298(5600):1911-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12471242</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 1993 May;14(5):222-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8517921</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 1999;17:931-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10358778</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Pharmacol. 2004 Mar 1;67(5):823-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15104235</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Urogynecol J. 2016 Jan;27(1):155-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26318612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2009 Oct;9(10):692-703</Citation><ArticleIdList><ArticleId IdType="pubmed">19859064</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2011 Sep 23;286(38):32891-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21799019</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1990 Dec 25;265(36):22079-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2148316</ArticleId></ArticleIdList></Reference><Reference><Citation>Food Sci Biotechnol. 2016 Oct 31;25(5):1437-1442</Citation><ArticleIdList><ArticleId IdType="pubmed">30263427</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2002 Dec;14(6):688-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12413516</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2020 Jan 1;521(1):72-76</Citation><ArticleIdList><ArticleId IdType="pubmed">31629474</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Pharmacol Sin. 2013 Oct;34(10):1270-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23974516</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis. 2005 Apr;26(4):845-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15637089</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Appl Immunol. 1991;94(1-4):51-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1834584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 1959 Nov;127:182-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14446178</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2012 Mar 30;143(1):34-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22305932</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1989 Apr 21;244(4902):334-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2523561</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2019 Jan 20;2019:7823761</Citation><ArticleIdList><ArticleId IdType="pubmed">30800677</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Prod Rep. 2017 Feb 1;34(2):194-219</Citation><ArticleIdList><ArticleId IdType="pubmed">27874907</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1989 Sep 15;264(26):15323-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2527850</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2003 Dec;15(6):639-46</Citation><ArticleIdList><ArticleId IdType="pubmed">14630197</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Allergy Asthma Rep. 2006 Sep;6(5):427-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16899206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutr Res Pract. 2010 Apr;4(2):93-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20461196</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 1999 Feb;14(1):18-28</Citation><ArticleIdList><ArticleId IdType="pubmed">10207726</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Investig Drugs. 2002 Jun;11(6):807-17</Citation><ArticleIdList><ArticleId IdType="pubmed">12036424</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pharm Res. 2002 Apr;25(2):170-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12009031</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Corée du Sud</li></country></list><tree><country name="Corée du Sud"><noRegion><name sortKey="Lee, Mina" sort="Lee, Mina" uniqKey="Lee M" first="Mina" last="Lee">Mina Lee</name></noRegion><name sortKey="Shim, Sun Yup" sort="Shim, Sun Yup" uniqKey="Shim S" first="Sun-Yup" last="Shim">Sun-Yup Shim</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PlantImRecepV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000130 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000130 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PlantImRecepV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32102220
|texte= Inhibitory Effects of Eriodictyol-7-O-β-d-glucuronide and 5,7-Dihydroxy-4-chromene Isolated from Chrysanthemum zawadskii var. latilobum in FcεRI-Mediated Human Basophilic KU812F Cell Activation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32102220" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PlantImRecepV1
| This area was generated with Dilib version V0.6.38. |  |